Drug Shortage Report for TEVA-LETROZOLE
| Report ID | 105590 |
| Drug Identification Number | 02343657 |
| Brand name | TEVA-LETROZOLE |
| Common or Proper name | LETROZOLE 2.5MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | LETROZOLE |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | L02BG |
| ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-02-06 |
| Estimated end date | 2021-02-28 |
| Actual end date | 2021-03-31 |
| Shortage status | Resolved |
| Updated date | 2021-04-01 |
| Company comments | Allocating to 100% of our market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2021-04-01 | English | Compare |